Sales Manager

At CSL Seqirus, we are committed to protecting communities through innovative vaccine solutions. We are seeking an experienced and commercially astute Sales Manager to join our team for a part-time (three days a week), 12 month-fixed term contract where you will lead our New Zealand sales team and drive business growth across the country.

Reporting to the Senior Director, Respiratory Vaccines, you will be responsible for maximising revenue and profitability across the portfolio through the development and execution of effective commercial strategies. As a key leader within our Commercial Operations team, you will inspire and develop a high-performing sales team and build strong relationships with healthcare professionals and key stakeholders.

Key responsibilities

• Lead, coach and develop a team of Territory Managers to achieve sales and business objectives.
• Translate marketing strategies into clear sales execution plans, priorities and KPIs.
• Drive sales performance and deliver or exceed budgeted targets.
• Develop annual business plans and account management strategies aligned with commercial objectives.
• Support formulary listings, protocol changes and product adoption within target healthcare institutions.
• Foster a positive growth culture through coaching, development planning and in-field leadership.

About you

• Degree qualification in Science, Pharmacy, Nursing, Business or a related discipline.
• Experience within the New Zealand pharmaceutical and/or vaccine industry.
• A strong sales background with proven commercial success.
• Demonstrated people leadership and team management experience.
• Pharmaceutical or vaccine sales management experience.
• Strong business acumen and strategic thinking capabilities.
• Experience coaching and developing high-performing teams.

About us

CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

Apply now!